GlassScriptPhysician profile
Michael Anthony Maccini
NPI 1861767121
$9,787.97
in general payments reported to CMS, 2019-2025
46 companies · $1,108 in 2025
The $1,108 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,675 · 2020: $337 · 2021: $814 · 2022: $2,172 · 2023: $644 · 2024: $3,038 · 2025: $1,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,038 · Travel and Lodging: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,037.57 |
| Travel and Lodging | $752.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,835.08 | 2021-2024 | Urolift |
| Neotract INC. | $1,003.61 | 2019-2020 | |
| Edap Technomed INC | $687.00 | 2024 | |
| Janssen Biotech, INC. | $582.31 | 2019-2025 | Erleada |
| Abbvie INC. | $502.15 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $375.91 | 2024-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $371.55 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $371.55 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $347.52 | 2019-2025 | Axonics |
| Bluewind Medical | $265.47 | 2024-2025 | Revi |
| Calyxo, INC. | $229.68 | 2025 | Cvac Aspiration System |
| Rochester Medical Corporation | $211.52 | 2021-2022 | |
| Procept Biorobotics Corporation | $173.94 | 2025 | |
| Urogen Pharma, INC. | $162.27 | 2024 | |
| Palette Life Sciences, INC. | $147.29 | 2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maccini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.